Geron (GERN) Change in Account Payables (2025 - 2026)
Geron recorded quarterly Change in Account Payables of $1.5 million in Q1 2026, up 359.86% quarter-over-quarter from -$563000.0 in Q1 2025, and up 359.86% year-over-year from $318141.8 in Q1 2025.
Geron's Change in Account Payables history runs 2 years deep, the most recent figure standing at $1.5 million for Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Geron | 846,759.37 | 846,759.37 | - | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.46 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Mar 31, 2025 | -563,000.00 |
| Mar 31, 2025 | -563,000.00 |